Literature DB >> 17900102

Calculation of lipophilicity of a large, diverse dataset of anticancer platinum complexes and the relation to cellular uptake.

Steven P Oldfield1, Matthew D Hall, James A Platts.   

Abstract

A quantitative structure--property relationship (QPSR) for the octanol--water partition of platinum complexes was constructed using molecular descriptors derived from density functional (DFT) calculations. A dataset of partition data for 64 complexes, consisting of 43 square-planar platinum(II) and 21 octahedral platinum(IV) complexes, was drawn from literature sources. Not only does this dataset include considerable structural diversity of complexes considered but also a variety of techniques for the measurement of partition coefficients. These data were modeled using descriptors drawn from electrostatic potentials and hardness/softness indices projected onto molecular surfaces. This required initial descriptor selection using a genetic algorithm approach, followed by partial least-squares regression against log Po/w data. In this way, a statistically robust model was constructed, with errors of similar size to the variation in log Po/w from multiple experimental measurements. Implications of lipophilicity for cellular accumulation of Pt-based drugs, and hence for design of new drugs, are discussed, as is the uptake of metabolites of cisplatin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17900102     DOI: 10.1021/jm0708275

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  12 in total

1.  Molecular and statistical modeling of reduction peak potential and lipophilicity of platinum(IV) complexes.

Authors:  James A Platts; Giuseppe Ermondi; Giulia Caron; Mauro Ravera; Elisabetta Gabano; Luca Gaviglio; Giorgio Pelosi; Domenico Osella
Journal:  J Biol Inorg Chem       Date:  2010-11-16       Impact factor: 3.358

2.  Conjugation of cisplatin analogues and cyclooxygenase inhibitors to overcome cisplatin resistance.

Authors:  Wilma Neumann; Brenda C Crews; Menyhárt B Sárosi; Cristina M Daniel; Kebreab Ghebreselasie; Matthias S Scholz; Lawrence J Marnett; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2014-10-15       Impact factor: 3.466

3.  Effect of reactivity on cellular accumulation and cytotoxicity of oxaliplatin analogues.

Authors:  Irina Buß; Ganna V Kalayda; Andreas Lindauer; Michael R Reithofer; Markus Galanski; Bernhard K Keppler; Ulrich Jaehde
Journal:  J Biol Inorg Chem       Date:  2012-03-29       Impact factor: 3.358

4.  Synthesis and antitumour evaluation of indole-2-carboxamides against paediatric brain cancer cells.

Authors:  Shahinda S R Alsayed; Amreena Suri; Anders W Bailey; Samuel Lane; Eryn L Werry; Chiang-Ching Huang; Li-Fang Yu; Michael Kassiou; Simone Treiger Sredni; Hendra Gunosewoyo
Journal:  RSC Med Chem       Date:  2021-08-23

5.  Synthesis of [PtCl2(4,4'-dialkoxy-2,2'-bipyridine)] complexes and their in vitro anticancer properties.

Authors:  Van Vo; Ontida Tanthmanatham; Haesook Han; Pradip K Bhowmik; Bryan L Spangelo
Journal:  Metallomics       Date:  2013-08       Impact factor: 4.526

6.  QM/MM investigation into binding of square-planar platinum complexes to DNA fragments.

Authors:  Konstantinos Gkionis; James A Platts
Journal:  J Biol Inorg Chem       Date:  2009-07-09       Impact factor: 3.358

7.  The interaction of silver(II) complexes with biological macromolecules and antioxidants.

Authors:  Katherine D Trotter; Olawale Owojaiye; Stuart P Meredith; Pat E Keating; Mark D Spicer; John Reglinski; Corinne M Spickett
Journal:  Biometals       Date:  2019-05-16       Impact factor: 2.949

Review 8.  Pt(IV) Prodrugs with NSAIDs as Axial Ligands.

Authors:  Daniil Spector; Olga Krasnovskaya; Kirill Pavlov; Alexander Erofeev; Peter Gorelkin; Elena Beloglazkina; Alexander Majouga
Journal:  Int J Mol Sci       Date:  2021-04-07       Impact factor: 5.923

9.  Unsymmetric mono- and dinuclear platinum(IV) complexes featuring an ethylene glycol moiety: synthesis, characterization, and biological activity.

Authors:  Verena Pichler; Petra Heffeter; Seied M Valiahdi; Christian R Kowol; Alexander Egger; Walter Berger; Michael A Jakupec; Mathea Sophia Galanski; Bernhard K Keppler
Journal:  J Med Chem       Date:  2012-12-17       Impact factor: 7.446

10.  Pt(iv) derivatives of cisplatin and oxaliplatin with phenylbutyrate axial ligands are potent cytotoxic agents that act by several mechanisms of action.

Authors:  Raji Raveendran; Jeremy Phillip Braude; Ezequiel Wexselblatt; Vojtech Novohradsky; Olga Stuchlikova; Viktor Brabec; Valentina Gandin; Dan Gibson
Journal:  Chem Sci       Date:  2016-01-15       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.